Population structure and properties of Candida albicans, as determined by multilocus sequence typing

Journal of Clinical Microbiology

Volumn 43, Issue 11, 2005, Pages 5601-5613

  Tavanti, Arianna ^a   Davidson, Amanda D ^a   Fordyce, Mark J ^a   Gow, Neil A R ^a   Maiden, Martin C J ^b   Odds, Frank C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ANATOMICAL SOURCE; ANATOMY; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CLADISTICS; FISHER EXACT TEST; FUNGAL COLONIZATION; FUNGAL GENE; FUNGAL VIRULENCE; FUR1 GENE; GENE LOCUS; GENE MUTATION; GENOTYPE; GEOGRAPHICAL SOURCE; GEOGRAPHY; HETEROZYGOSITY; HOMOZYGOSITY; IN VITRO SELECTION; MATING TYPE LIKE LOCUS; MOLECULAR PHYLOGENY; MULTILOCUS SEQUENCE TYPING; MYCOSIS; NONHUMAN; POPULATION STRUCTURE; PRIORITY JOURNAL; SELECTION PRESSURE; TIME; VARIANCE;

ANALYSIS OF VARIANCE; ANTIFUNGAL AGENTS; BLOOD; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; EUROPE; FEMALE; GENES, FUNGAL; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; NORTH AMERICA; OROPHARYNX; PHYLOGENY; SEQUENCE ANALYSIS; SPECIES SPECIFICITY; VAGINA;

CANDIDA ALBICANS;

EID: 27744549756     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.11.5601-5613.2005     Document Type: Article

References (52)

1. Anderson, J. M., and D. R. Soll. 1987. The unique phenotype of opaque cells in the "white-opaque transition" in Candida albicans. J. Bacteriol. 169:5579-5588.
2. Blignaut, E., C. Pujol, S. Lockhart, S. Joly, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa. J. Clin. Microbiol. 40:826-836.
3. Blignaut, E., C. Pujol, S. Lockhart, S. Joly, and D. R. Soll. 2002. A new clade of Candida albicans among South African oral yeast isolates. J. Dent. Res. 81:2231.
4. Bougnoux, M.-E., A. D. M., S. Morand, M. Théraud, B. G. Spratt, and C. d'Enfert. 2004. Multilocus sequence typing of Candida albicans: strategies, data exchange and applications. Infect. Genet. Evol. 4:243-252.
5. Bougnoux, M.-E., S. Morand, and C. d'Enfert. 2002. Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans. J. Clin. Microbiol. 40:1290-1297.
6. Bougnoux, M. E., A. Tavanti, C. Bouchier, N. A. R. Gow, A. Magnier, A. D. Davidson, M. C. J. Maiden, C. d'Enfert, and F. C. Odds. 2003. Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J. Clin. Microbiol. 41:5265-5266.
7. Burnie, J. P., F. C. Odds, W. Lee, C. Webster, and J. D. Williams. 1985. Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Brit. Med. J. 290:746-748.
8. Calderone, R. A. 2002. Candida and candidiasis. ASM Press, Washington, D.C.
9. Chan, M. S., M. C. J. Maiden, and B. G. Spratt. 2001. Database-driven multi locus sequence typing (MLST) of bacterial pathogens. Bioinformatics 17: 1077-1083.
10. Clemons, K. V., F. Feroze, K. Holmberg, and D. A. Stevens. 1997. Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods. J. Clin. Microbiol. 35:1332-1336.
11. Coste, A. T., M. Karababa, F. Ischer, J. Bille, and D. Sanglard. 2004. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3:1639-1652.
12. Cowen, L. E., A. Nantel, M. S. Whiteway, D. Y. Thomas, D. C. Tessier, L. M. Kohn, and J. B. Anderson. 2002. Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA 99:9284-9289.
13. Cowen, L. E., D. Sanglard, D. Calabrese, C. Sirjusingh, J. B. Anderson, and L. M. Kohn. 2000. Evolution of drug resistance in experimental populations of Candida albicans. J. Bacteriol. 182:1515-1522.
14. Dodgson, A. R., K. J. Dodgson, C. Pujol, M. A. Pfaller, and D. R. Soll. 2004. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob. Agents Chemother. 48: 2223-2227.
15. Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
16. Fonzi, W., and M. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
17. Forche, A., G. Schönian, Y. Gräser, R. Vilgalys, and T. G. Mitchell. 1999. Genetic structure of typical and atypical populations of Candida albicans from Africa. Fungal Genet. Biol. 28:107-125.
18. Hope, W. W., L. Tabernero, D. W. Denning, and M. J. Anderson. 2004. Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob. Agents Chemother. 78:4377-4386.
19. Horsburgh, C. R., and C. H. Kirkpatrick. 1983. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am. J. Med. 74:23-29.
20. Hunter, P. R. 1990. Reproducibility and indices of discriminatory power of microbial typing methods. J. Clin. Microbiol. 28:1903-1905.
21. Jones, T., N. A. Federspiel, H. Chibana, J. Dungan, S. Kalman, B. B. Magee, G. Newport, Y. R. Thorstenson, N. Agabian, P. T. Magee, R. W. Davis, and S. Scherer. 2004. The diploid genome sequence of Candida albicans. Proc. Natl. Acad. Sci. USA 101:7329-7334.
22. Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: Molecular Evolutionary Genetics Analysis software. Bioinformatics 17:1244-1245.
23. Lett, T. J., and M. M. Effat. 2001. Evidence for a more recently evolved clade within a Candida albicans North American population. Microbiology 147: 1687-1692.
24. Lott, T. J., R. E. Fundyga, M. E. Brandt, L. H. Harrison, A. N. Sofair, R. A. Hajjeh, and D. W. Warnock. 2003. Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from TJS population-based surveillance isolates. J. Clin. Microbiol. 41:1316-1321.
25. Mackenzie, D. W. R., and F. C. Odds. 1991. Non-identity and authentication of two major reference strains of Candida albicans. J. Med. Vet. Mycol. 29:255-261.
26. McCullough, M. J., K. V. Clemons, and D. A. Stevens. 1999. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J. Clin. Microbiol. 37:417-421.
27. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 2nd ed., vol. 17(9). NCCLS, Wayne, Pa.
28. Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailliere Tindall, London, United Kingdom.
29. Odds, F. C. 1991. Long-term preservation of pathogenic yeasts under distilled water. J. Med. Vet. Mycol. 29:413-415.
30. Odds, F. C., A. B. Abbott, R. L. Stiller, H. J. Scholer, A. Polak, and D. A. Stevens. 1983. Analysis of Candida albicans phenotypes from different geographical and anatomical sources. J. Clin. Microbiol. 18:849-857.
31. Odds, F. C., C. C. Kibbler, E. Walker, A. Bhamra, H. G. Prentice, and P. Noone. 1989. Carriage of Candida species and C. albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease. J. Clin. Pathol. 42:1259-1266.
32. Odds, F. C., L. Van Nuffel, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36:2869-2873.
33. Odds, F. C., L. Vranckx, and F. Woestenborghs. 1995. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob. Agents Chemother. 39:2051-2060.
34. Pfaller, M. A., and D. J. Diekema. 2004. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin. Microbiol. Infect. 10(Suppl. 1):11-23.
35. Pujol, C., S. A. Messer, M. Pfaller, and D. R. Soll. 2003. Drug resistance is not directly affected by mating type locus zygosity in Candida albicans. Antimicrob Agents Chemother. 47:1207-1212.
36. Pujol, C., M. Pfaller, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade. J. Clin. Microbiol. 40:2729-2740.
37. Pujol, C., M. A. Pfaller, and D. R. Soll. 2004. Flucytosine resistance is restricted to a single genetic clade of Candida albicans. Antimicrob. Agents Chemother. 48:262-266.
38. Redding, S., J. Smith, G. Farinacci, M. Riruildi, A. Fothergill, J. Rhinechalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS-documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
39. Rex, J. H., C. R. Cooper, W. G. Merz, J. N. Galgiani, and E. J. Anaissie. 1995. Detection of amphoteriein B-resistant Candida isolates in a broth-based system. Antimicrob. Agents Chemother. 39:906-909.
40. Rustad, T. R., D. A. Stevens, M. A. Pfaller, and T. C. White. 2002. Homozygosity at the Candida albicans MTL locus associated with azole resistance. Microbiology 148:1061-1072.
41. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
42. Schmid, J., S. Herd, P. R. Hunter, R. D. Cannon, M. S. M. Yasin, S. Samad, M. Carr, D. Parr, W. McKinney, M. Schousboe, B. Harris, R. Ikram, M. Harris, A. Restrepo, G. Hoyos, and K. P. Singh. 1999. Evidence for a general-purpose genotype in Candida albicans, highly prevalent in multiple geographical regions, patient types and types of infection. Microbiology 145:2405-2413.
43. Schmid, J., P. R. Hunter, G. C. White, A. K. Nand, and R. D. Cannon. 1995. Physiological traits associated with success of Candida albicans strains as commensal colonizers and pathogens. J. Clin. Microbiol. 33:2920-2926.
44. Schonian, G., A. Forche, H. J. Tietz, M. Muller, Y. Graser, R. Vilgalys, T. G. Mitchell, and W. Presber. 2000. Genetic structure of geographically different populations of Candida albicans. Mycoses 43:51-56.
45. Soll, D. R. 2004. Mating-type locus homozygosis, phenotypic switching and mating: a unique sequence of dependencies in Candida albicans. Bioessays 26:10-20.
46. Soll, D. R., and C. Pujol. 2003. Candida albicans clades. FEMS Immunol. Med. Microbiol. 39:1-7.
47. Tavanti, A., A. D. Davidson, N. A. R. Gow, M. C. J. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida melapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.
48. Tavanti, A., N. A. R. Gow, S. Senesi, M. C. J. Maiden, and F. C. Odds. 2003. optimization and validation of multilocus sequence typing for Candida albicans. J. Clin. Microbiol. 41:3765-3776.
49. Tietz, H. J., M. Hopp, A. Schmalreck, W. Sterry, and V. Czaika. 2001. Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses 44:437-445.
50. Urwin, R., and M. C. J. Maiden. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11:479-487.
51. White, T. C. 1997. Increased mRNA levels of EKG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
52. Wirsching, S., S. Michel, and J. Morschhauser. 2000. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol. Microbiol. 36:856-865.